Administration of spironolactone (10 and 20 mg/kg) significantly attenuated chronic constriction injury-induced pain related behaviour and foot deformity along with attenuation of TNF-&#945; levels, without modulating vincristine-induced neuropathic pain.
C0027796
Neuralgia